Dyne Therapeutics Stock Forecast - Market Facilitation Index

DYN Stock  USD 28.33  0.34  1.19%   
Dyne Stock Forecast is based on your current time horizon. Although Dyne Therapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Dyne Therapeutics' systematic risk associated with finding meaningful patterns of Dyne Therapeutics fundamentals over time.
  
As of the 11th of December 2024, Inventory Turnover is likely to grow to 8.49, while Payables Turnover is likely to drop 0.10. . As of the 11th of December 2024, Common Stock Shares Outstanding is likely to drop to about 56.7 M. In addition to that, Net Loss is likely to grow to about (143.7 M).
On December 2, 2024 Dyne Therapeutics had Market Facilitation Index of 0. Market Facilitation Index is simply a difference between period high and low prices divided by period trading volume.
Check Dyne Therapeutics VolatilityBacktest Dyne TherapeuticsTrend Details  

Dyne Therapeutics Trading Date Momentum

On December 03 2024 Dyne Therapeutics was traded for  28.17  at the closing time. Highest Dyne Therapeutics's price during the trading hours was 29.42  and the lowest price during the day was  27.99 . The net volume was 806.2 K. The overall trading history on the 3rd of December contributed to the next trading period price depreciation. The overall trading delta to the next next day price was 3.79% . The overall trading delta to current price is 0.07% .
Market Facilitation Index was developed by Dr. Bill Williams. This indicator can help to determine either strong or week signal that can follow the current trend line by looking at how Market Facilitation index correlates with trading volume over time.
Compare Dyne Therapeutics to competition

Other Forecasting Options for Dyne Therapeutics

For every potential investor in Dyne, whether a beginner or expert, Dyne Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Dyne Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Dyne. Basic forecasting techniques help filter out the noise by identifying Dyne Therapeutics' price trends.

Dyne Therapeutics Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Dyne Therapeutics stock to make a market-neutral strategy. Peer analysis of Dyne Therapeutics could also be used in its relative valuation, which is a method of valuing Dyne Therapeutics by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Dyne Therapeutics Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Dyne Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Dyne Therapeutics' current price.

Dyne Therapeutics Market Strength Events

Market strength indicators help investors to evaluate how Dyne Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Dyne Therapeutics shares will generate the highest return on investment. By undertsting and applying Dyne Therapeutics stock market strength indicators, traders can identify Dyne Therapeutics entry and exit signals to maximize returns.

Dyne Therapeutics Risk Indicators

The analysis of Dyne Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Dyne Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting dyne stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Pair Trading with Dyne Therapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Dyne Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dyne Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Moving against Dyne Stock

  0.74GILD Gilead SciencesPairCorr
  0.73BMY Bristol Myers SquibbPairCorr
  0.66ESPR Esperion TherapeuticsPairCorr
  0.38DYAI Dyadic InternationalPairCorr
The ability to find closely correlated positions to Dyne Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Dyne Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Dyne Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Dyne Therapeutics to buy it.
The correlation of Dyne Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Dyne Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Dyne Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Dyne Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Dyne Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Dyne Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Dyne Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Dyne Therapeutics Stock:
Check out Historical Fundamental Analysis of Dyne Therapeutics to cross-verify your projections.
To learn how to invest in Dyne Stock, please use our How to Invest in Dyne Therapeutics guide.
You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dyne Therapeutics. If investors know Dyne will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dyne Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.58)
Return On Assets
(0.40)
Return On Equity
(0.69)
The market value of Dyne Therapeutics is measured differently than its book value, which is the value of Dyne that is recorded on the company's balance sheet. Investors also form their own opinion of Dyne Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Dyne Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dyne Therapeutics' market value can be influenced by many factors that don't directly affect Dyne Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dyne Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Dyne Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dyne Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.